Covidien completes tender offer for ev3 stake
Dublin, July 13, 2010
Covidien, a Dublin-based global provider of healthcare products, has completed its tender offer to purchase all of the outstanding shares of common stock of ev3, a leading developer and marketer of endovascular devices.
The tender offer was made through Covidien’s subsidiary, COV Delaware Corporation. The offer expired on July 9, and was not extended.
The depositary for the tender offer has advised Covidien that, as of the expiration of the offering period, a total of approximately 100,814,535 shares of ev3 common stock were validly tendered and not withdrawn, representing approximately 87.7 per cent of the outstanding ev3 common shares.
All shares that were validly tendered and not withdrawn during the initial offering period have been accepted for payment, a statement said.
Pursuant to the terms of the merger agreement, COV Delaware Corporation will exercise its option to purchase newly issued shares from ev3 at the tender offer price, which will permit Covidien to complete the acquisition process by effecting a short-form merger as promptly as practicable, that is, without a vote or meeting of ev3’s remaining stockholders.
Following the merger, ev3 will become an indirect wholly-owned subsidiary of Covidien, the statement added.
Each share of ev3’s outstanding common stock will be cancelled and converted into the right to receive the same consideration, without interest, received by holders who tendered in the tender offer.
Thereafter, ev3 common stock will cease to be traded on the Nasdaq, according to the statement. – TradeArabia News Service
More Health & Environment Stories
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership
- Need for medical simulation training highlighted
- UAE-France discuss healthcare collaboration
- Seha focus on patient centred services
- Saudi-Tokyo firms in wastewater technology JV
- Leading experts at Dubai diabetes conference
- UAE reliance on green energy on the rise
- DB unit backs therapeutic riding programme